Free Trial

Novavax (NVAX) SEC Filings & 10K Form

Novavax logo
$7.87 -0.46 (-5.52%)
Closing price 04:00 PM Eastern
Extended Trading
$7.96 +0.09 (+1.21%)
As of 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Novavax SEC Filings

DateFilerForm TypeView
02/27/2025
7:05 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:41 AM
Novavax (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2025
6:04 PM
MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:06 PM
Alton Gregg H (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Novavax (Subject)
Form SCHEDULE 13G/A
01/27/2025
5:19 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:50 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
4:41 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:52 PM
Novavax (Issuer)
Rodgers Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:44 PM
Novavax (Issuer)
YOUNG JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:47 PM
King Rachel K. (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:02 PM
Novavax (Subject)
YOUNG JAMES F (Reporting)
Form 144/A
12/30/2024
4:27 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
9:31 AM
Novavax (Subject)
YOUNG JAMES F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
4:24 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:24 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
11:13 AM
King Rachel K. (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2024
5:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:05 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
3:08 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:21 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:01 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:19 PM
Novavax (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:08 PM
Dubovsky Filip (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:47 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
4:06 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:04 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:37 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
5:16 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/20/2024
4:08 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:35 PM
Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
Form SC 13G/A
06/06/2024
6:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
8:35 PM
Novavax (Filer)
Form DEFA14A
05/20/2024
1:42 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/20/2024
5:09 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/15/2024
8:15 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
1:39 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:05 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:53 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
The Deep State Surveillance Plot To Sabotage President Trump (Ad)

There's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your retirement savings into a private safe-haven, free of chaos and market manipulation.

05/07/2024
4:21 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
1:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/06/2024
3:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/06/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form PREC14A
04/29/2024
6:58 AM
Novavax (Filer)
Form DEFA14A
04/29/2024
7:01 AM
Novavax (Filer)
Form ARS
04/29/2024
6:54 AM
Novavax (Filer)
Form DEF 14A
04/15/2024
11:18 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
04/15/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D
03/26/2024
6:00 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:00 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:01 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:02 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:03 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
5:11 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:45 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:39 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:30 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVAX) was last updated on 3/3/2025 by MarketBeat.com Staff
From Our Partners